| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ABT-263 | CTRPv2 | pan-cancer | AAC | -0.093 | 0.008 |
| mRNA | ML203 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.008 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | -0.077 | 0.008 |
| mRNA | RITA | CTRPv2 | pan-cancer | AAC | -0.094 | 0.008 |
| mRNA | BRD-K70511574 | CTRPv2 | pan-cancer | AAC | -0.084 | 0.008 |
| mRNA | vorinostat:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.092 | 0.009 |
| mRNA | TPCA-1 | CTRPv2 | pan-cancer | AAC | -0.084 | 0.009 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | -0.081 | 0.009 |
| mRNA | Parthenolide | GDSC1000 | pan-cancer | AAC | -0.14 | 0.009 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | -0.072 | 0.009 |